All Work

Chris Lange

Sutro Biopharma Gears Up for IPO

Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.

Chris Lange · 8 years ago

Should Elon Musk Face Even More Scrutiny?

In the past, Elon Musk has been recognized in his eccentricities and Tesla’s stock has been moved solely on his tweets, but this month has been nothing short of a circus.

Chris Lange · 8 years ago

Elanco Closes in on IPO

Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.

Chris Lange · 8 years ago

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a positive day for the broad U.S. markets, with the S&P 500 and Nasdaq hitting new all-time highs in the session. The DJIA again hit its highest level since early February. Crude…

Chris Lange · 8 years ago

Papa John’s Founder Slices Up Senior Management

In the latest chapter of drama from Papa John’s, founder John Schnatter penned a poignant letter to franchisees regarding the state of the company. Schnatter made strong accusations regarding the company’s poor financial performance…

Chris Lange · 8 years ago

Chipotle Doubles Down on DoorDash

Chipotle originally partnered with the food delivery service DoorDash back in April, but now it seems that the burrito chain is doubling down.

Chris Lange · 8 years ago

Why Akcea and Ionis Are Getting Crushed

Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.

Chris Lange · 8 years ago